ClinicalTrials.Veeva

Menu

Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis (AMI-ER)

S

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status

Enrolling

Conditions

Cardiomyopathy

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

observational epidemiological study of patients affected by systemic amyloidosis

Enrollment

750 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients diagnosed with amyloidosis or asymptomatic carriers of mutations in the transthyretin gene
  • minimum age of 18 years at the time of diagnosis
  • obtaining informed consent

Exclusion criteria

  • nothing

Trial contacts and locations

1

Loading...

Central trial contact

simone longhi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems